Abstract
The global market for small joint implants will experience healthy growth
through 2015. Regional markets, such as the U.S., Europe, Asia-Pacific (AP)
and the Rest-of-the-World (ROW) will be distinguished by the prevalence of
conditions that contribute to small joint disease, the availability of
different products, and factors influencing the provision of healthcare.
In the U.S., growth will be influenced by the adoption of products that have
only been available overseas, preference for motion-preserving technologies
over fusion, and challenges with respect to reimbursement and coverage. In
Europe, where aging populations will contribute to the demand for small joint
implants, cost-containment efforts will influence prices and product
purchases. AP and ROW countries feature differences in disease prevalence,
demographics, and processes for reimbursement, regulatory approval, and
product distribution.
This report examines the market for replacement, fixation, and fusion implants
for the shoulder, elbow, wrist, fingers, ankle and foot, and provides a
detailed analysis of the clinical and economic factors driving regional
markets.
|